219 related articles for article (PubMed ID: 11421567)
1. Use of soy protein supplement and resultant need for increased dose of levothyroxine.
Bell DS; Ovalle F
Endocr Pract; 2001; 7(3):193-4. PubMed ID: 11421567
[TBL] [Abstract][Full Text] [Related]
2. Unawareness of the effects of soy intake on the management of congenital hypothyroidism.
Fruzza AG; Demeterco-Berggren C; Jones KL
Pediatrics; 2012 Sep; 130(3):e699-702. PubMed ID: 22908106
[TBL] [Abstract][Full Text] [Related]
3. Unusual malabsorption of levothyroxine.
Jauk B; Mikosch P; Gallowitsch HJ; Kresnik E; Molnar M; Gomez I; Lind P
Thyroid; 2000 Jan; 10(1):93-5. PubMed ID: 10691319
[TBL] [Abstract][Full Text] [Related]
4. Levothyroxine pseudomalabsorption and thyroxine absorption testing with use of high-dose levothyroxine: case report and discussion.
Srinivas V; Oyibo SO
Endocr Pract; 2010; 16(6):1012-5. PubMed ID: 21041167
[TBL] [Abstract][Full Text] [Related]
5. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
Benvenga S; Di Bari F; Vita R
Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
[TBL] [Abstract][Full Text] [Related]
6. Soy isoflavones inducing overt hypothyroidism in a patient with chronic lymphocytic thyroiditis: a case report.
Nakamura Y; Ohsawa I; Goto Y; Tsuji M; Oguchi T; Sato N; Kiuchi Y; Fukumura M; Inagaki M; Gotoh H
J Med Case Rep; 2017 Sep; 11(1):253. PubMed ID: 28870235
[TBL] [Abstract][Full Text] [Related]
7. Abnormal thyroid function tests in infants with congenital hypothyroidism: the influence of soy-based formula.
Jabbar MA; Larrea J; Shaw RA
J Am Coll Nutr; 1997 Jun; 16(3):280-2. PubMed ID: 9176836
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
9. Difficulties in diagnosing and managing coexisting primary hypothyroidism and resistance to thyroid hormone.
Tran HA
Endocr Pract; 2006; 12(3):288-93. PubMed ID: 16772202
[TBL] [Abstract][Full Text] [Related]
10. Impaired enteral levothyroxine absorption in hypothyroidism refractory to oral therapy after thyroid ablation for papillary thyroid cancer: case report and kinetic studies.
Tönjes A; Karger S; Koch CA; Paschke R; Tannapfel A; Stumvoll M; Fuhrer D
Thyroid; 2006 Oct; 16(10):1047-51. PubMed ID: 17042692
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
Ain KB; Pucino F; Shiver TM; Banks SM
Thyroid; 1993; 3(2):81-5. PubMed ID: 8369656
[TBL] [Abstract][Full Text] [Related]
12. Timing of levothyroxine administration affects serum thyrotropin concentration.
Bach-Huynh TG; Nayak B; Loh J; Soldin S; Jonklaas J
J Clin Endocrinol Metab; 2009 Oct; 94(10):3905-12. PubMed ID: 19584184
[TBL] [Abstract][Full Text] [Related]
13. Tablet formulation of levothyroxine is absorbed less well than powdered levothyroxine.
Yamamoto T
Thyroid; 2003 Dec; 13(12):1177-81. PubMed ID: 14751040
[TBL] [Abstract][Full Text] [Related]
14. Pseudomalabsorption of levothyroxine: a case report.
Ogawa D; Otsuka F; Mimura U; Ueno A; Hashimoto H; Kishida M; Ogura T; Makino H
Endocr J; 2000 Feb; 47(1):45-50. PubMed ID: 10811292
[TBL] [Abstract][Full Text] [Related]
15. Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders.
Csako G; McGriff NJ; Rotman-Pikielny P; Sarlis NJ; Pucino F
Ann Pharmacother; 2001 Dec; 35(12):1578-83. PubMed ID: 11793625
[TBL] [Abstract][Full Text] [Related]
16. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
Ito M; Miyauchi A; Morita S; Kudo T; Nishihara E; Kihara M; Takamura Y; Ito Y; Kobayashi K; Miya A; Kubota S; Amino N
Eur J Endocrinol; 2012 Sep; 167(3):373-8. PubMed ID: 22711760
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers.
Persiani S; Sala F; Manzotti C; Colovic M; Zangarini M; Donazzolo Y; Barbetta B; Vitalini C; Giacovelli G; Benvenuti C; Rovati LC
Drug Res (Stuttg); 2016 Mar; 66(3):136-40. PubMed ID: 26125285
[TBL] [Abstract][Full Text] [Related]
18. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
[TBL] [Abstract][Full Text] [Related]
19. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
Green WL
AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
[TBL] [Abstract][Full Text] [Related]
20. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
